Chemokines and chemokine receptors in inflammation of the nervous system: Manifold roles and exquisite regulation

Immunological Reviews

Volumn 177, Issue , 2000, Pages 52-67

  Huang, D ^a   Han, Y ^a   Rani, M R S ^a   Glabinski, A ^a   Trebst, C ^a   Sorensen, T ^a   Tani, M ^a   Wang, J ^a   Chien, P ^a   O'Bryan, S ^a   Bielecki, B ^a   Zhou, Z L ^a   Majumder, S ^a   Ransohoff, R M ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOATTRACTANT; CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR5; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; MONOCYTE CHEMOTACTIC PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ENCEPHALOMYELITIS; ASTROCYTE; CENTRAL NERVOUS SYSTEM; GENE CONTROL; GENE INDUCTION; GENETIC TRANSCRIPTION; GLIA CELL; INFLAMMATION; LEUKOCYTE ACTIVATION; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; REVIEW; TRANSCRIPTION REGULATION;

EID: 0033646462     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-065X.2000.17709.x     Document Type: Review

References (119)

1. Mechanisms of inflammation in MS tissue: Adhesion molecules and chemokines
2. Nervous tissue as an immune compartment: The dialect of the immune response in the CNS
3. Leukocyte-endothelial cell recognition: Three (or more) steps to specificity and diversity
4. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm
5. Lymphocyte homing and homeostasis
6. Chemokines and leukocyte traffic
7. Chemokines: Function, regulation and alteration of inflammatory responses
8. Chemokines: A new classification system and their role in immunity
9. Chemokines
10. Human chemokines: An update
11. Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice
12. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development
13. Fractalkine - A strange attractor in the chemokine landscape
14. Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation
15. Cloning, chromosomal localization, and RNA expression of a human β chemokine receptor-like gene
16. Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion
17. cDNA cloning of a G-protein-coupled receptor expressed in rat spinal cord and brain related to chemokine receptors
18. Neuronal expression of fractalkine in the presence and absence of inflammation
19. Localization of fractalkine and CX3CR1 mRNAs in rat brain: Does fractalkine play a role in signaling from neuron to microglia?
20. Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia
21. Cultured rat microglia express functional β-chemokine receptors
22. Perivascular microglial cells of the CNS are bone marrow derived and present antigen in vivo
23. Chemokine regulation of experimental autoimmune encephalomyelitis: Temporal and spatial expression patterns govern disease pathogenesis
24. Etiology and pathogenesis of multiple sclerosis
25. Chemokine receptors as therapeutic targets in multiple sclerosis
26. Experimental allergic encephalomyelitis: The balance between encephalitogenic T lymphocytes and demyelinating antibodies determines size and structure of demyelinated lesions
27. Neuropathology in multiple sclerosis: New concepts
28. The lesion in multiple sclerosis: Clinical, pathological, and magnetic resonance imaging considerations
29. The CCR5 deletion mutation fails to protect against multiple sclerosis
30. Chemokine-enhanced migration of human peripheral blood mononuclear cells is antagonized by interferon β 1b through an effect on matrix metalloproteinase-9
31. Perivascular T cells express the pro-inflammatory chemokine RANTES mRNA in multiple sclerosis lesions
32. MCP-1, MCP-2 and MCP-3 expression in multiple sclerosis lesions: An immunohistochemical and in situ hybridization study
33. No evidence for elevated numbers of mononuclear cells expressing MCP-1 and RANTES mRNA in blood and CSF in multiple sclerosis
34. Expression of monocyte chemoattractant protein-1 and other β-chemokines by resident glia and inflammatory cells in multiple sclerosis lesions
35. + myelin peptide-specific T cells: Importance of IFN-inducible protein 10
36. + T cells are increased in multiple sclerosis and their ligands MIP-1α and IP-10 are expressed in demyelinating brain lesions
37. Expression of MCP-1 by reactive astrocytes in demyelinating multiple sclerosis lesions
38. Microsatellite polymorphisms in the gene promoter of monocyte chemotactic protein-3 and analysis of the association between monocyte chemotactic protein-3 alleles and multiple sclerosis development
39. Analysis of gene expression in mutiple sclerosis lesions using cDNA microarrays
40. CCR5 832, matrix metalloproteinase-9 and disease activity in multiple sclerosis
41. + interferon-γ- and tumor necrosis factor-α-secreting T lymphocytes in multiple sclerosis patients
42. CC-chemokine receptor 5 polymorphism and age of onset in familial multiple sclerosis
43. Expression of specific chemokines and chemokine receptors in the central nervous system of mutiple sclerosis patients
44. Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1
45. Chemokines in the cerebrospinal fluid of patients with meningitis
46. C-X-C and C-C chemokines are expressed in the cerebrospinal fluid in bacterial meningitis and mediate chemotactic activity on peripheral blood-derived polymorphonuclear and mononuclear cells in vitro
47. Chemotactic activity on mononuclear cells in the cerebrospinal fluid of patients with viral meningitis is mediated by interferon-γ inducible protein-10 and monocyte chemotactic protein-1
48. Chemokines and chemotaxis of leukocytes in infectious meningitis
49. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes
50. Expression of specific chemokines and chemokine receptors in the central nervous system of mutiple sclerosis patients
51. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions
52. The role of macrophages in Wallerian degeneration
53. Macrophage responses and myelin clearance during Wallerian degeneration: Relevance to immune-mediated demyelination
54. Basic pathologic processes in the nervous system
55. Macrophage responses in inflammatory demyelinating neuropathies
56. The CNS acute inflammatory response to excitotoxic cell death
57. Cellular inflammatory response after spinal cord injury in Sprague-Dawley and Lewis rats
58. Delayed macrophage responses and myelin clearance during Wallerian degeneration in the central nervous system: The dorsal radiculotomy model
59. Experimental autoimmune panencephalitis and uveoretinitis transferred to the Lewis rat by T lymphocytes specific for the S100 β molecule, a calcium binding protein of astroglia
60. T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system
61. Mechanisms of immune injury in multiple sclerosis
62. Astrocyte expression of mRNA encoding cytokines IP-10 and JE/MCP-1 in experimental autoimmune encephalomyelitis
63. Chemokine monocyte chemoattractant protein-1 (MCP-1) is expressed by astrocytes after mechanical injury to the brain
64. Synchronous synthesis of α- and β-chemokines by cells of diverse lineage in the central nervous system of mice with relapses of experimental autoimmune encephalomyelitis
65. Chemokines in neurological disease models: Correlation between chemokine expression patterns and inflammatory pathology
66. Do chemokines mediate leukocyte recruitment in post-traumatic CNS inflammation?
67. Experimental autoimmune encephalomyelitis as a model of multiple sclerosis and immune-mediated CNS inflammation
68. A predictable sequential pattern of determinant spreading invariably accompanies progression of experimental autoimmune encephalomyelitis: A basis for peptide-specific therapy after onset of clinical disease
69. Interferon-β inhibits progression of relapsing-remitting experimental autoimmune encephalomyelitis
70. Kinetics and cellular origin of cytokines in the central nervous system: Insight into mechanisms of myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis
71. Central nervous system chemokine gene expression follows leukocyte entry in acute murine experimental autoimmune encephalomyelitis
72. Expression of chemokines RANTES, MIP-1α and GROα correlates with inflammation in acute experimental autoimmune encephalomyelitis
73. Reactive astrogliosis in the neonatal mouse brain and its modulation by cytokines
74. Expression of the chemokine MCP-1 and nitric oxide synthase-2 following cerebral trauma
75. An electrochemical spinal injury device with dynamic sensitivity
76. Selective chemokine mRNA accumulation in the rat spinal cord after contusion injury
77. In situ hybridization analysis of glial fibrillary acidic protein mRNA reveals evidence of biphasic astrocyte activation during acute experimental autoimmune encephalomyelitis
78. Differential and time-dependent expression of monocyte chemoattractant protein-1 mRNA by astrocytes and macrophages in rat brain: Effects of ischemia and peripheral lipopolysaccharide administration
79. Localization of macrophage inflammatory protein: Macrophage inflammatory protein-1 expression in rat brain after peripheral administration of lipopolysaccharide and focal cerebral ischemia
80. Neutrophil infiltration, glial reaction and neurological disease in transgenic mice expressing the chemokine N51/KC in oligodendrocytes
81. The chemokine GRO-α amplifies PDGF-induced proliferation of spinal cord oligodendrocyte progenitors
82. Elevated levels of the chemokine GRO-1 correlate with elevated oligodendrocyte progenitor proliferation in the jimpy mutant
83. Do chemokines mediate inflammatory cell invasion of the central nervous system parenchyma?
84. Direct injection of cytokines into the spinal cord causes autoimmune encephalomyelitis-like inflammation
85. Chemokines in immune-mediated inflammation of the central nervous system
86. Chemokine expression in GKO mice (lacking interferon-γ) with experimental autoimmune encephalomyelitis
87. Cellular responses to interferons and other cytokines: The JAK-STAT paradigm
88. JAK-STAT pathways and transcriptional activation in response to interferons and other extracellular signaling proteins
89. In vivo properties of monocyte chemoattractant protein-1
90. Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice
91. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice
92. MCP-1 deficiency reduces susceptibility to atherosclerosis m mice that overexpress human apolipoprotein B
93. TNF regulates the in vivo occupancy of both distal and proximal regulatory regions of the MCP-1/JE gene
94. A novel 7-nucleotide motif located in 3' untranslated sequences of the immediate-early gene set mediates platelet-derived growth factor induction of the JE gene
95. Interferon-γ induction of the human monocyte chemoattractant (hMCP)-1 gene in astrocytoma cells: Functional interaction between a γ-activated site (GAS) and GC-rich element
96. Regulation of monocyte chemoattractant protein-1 by interferon-γ in human astrocytoma cells: Post-inducing refractory state of the gene, governed by its upstream elements
97. Transcriptional regulation of chemokine gene expression in astrocytes
98. Sp1 binding is critical for promoter assembly and activation of the MCP-1 gene by tumor necrosis factor
99. trans-Retinoic acid blocks platelet-derived growth factor-BB-induced expression of the murine monocyte chemoattractant-1 gene by blocking the assembly of a promoter proximal Sp1 binding site
100. γ-Interferon transcriptionally regulates an early-response gene containing homology to platelet proteins
101. Expression of chemokine genes in rat glial cells: The effect of myelin basic protein-reactive encephalitogenic T cells
102. Interferon-γ-inducible genes in primary glial cells of the central nervous system: Comparisons of astrocytes with microglia and Lewis with brown Norway rats
103. Dynamic regulation of α- and β-chemokine expression in the central nervous system during mouse hepatitis virus-induced demyelinating disease
104. Prolonged expression of interferon-inducible protein-10 in ischemic cortex after permanent occlusion of the middle cerebral artery in rat
105. Lipopolysaccharide-induced expression of IP-10 mRNA in rat brain and in cultured rat astrocytes and microglia
106. Cytokine regulation of CC and CXC chemokine expression by human astrocytes
107. Expression of nitric oxide synthase (NOS)-2 following permanent focal ischemia and the role of nitric oxide in infarct generation in male, female and NOS-2 gene-deficient mice
108. Regulatory mechanisms of MuRantes and CRG-2 chemokine gene induction in central nervous system glial cells by virus
109. The interferon-stimulated response element and a κB site mediate synergistic induction of murine IP-10 gene transcription by IFN-γ and TNF-α
110. Regulation of human IP-10 gene expression in astrocytoma cells by inflammatory cytokines
111. p48/STAT-1α-containing complexes play a predominant role in induction of IP-10 by interferon-γ alone or in synergy with tumor necrosis factor-α
112. Characterization of β-R1, a gene that is selectively induced by IFN-β compared with IFN-α
113. Interferon-inducible T cell α chemoattractant (I-TAC): A novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3
114. Human IP-9: A keratinocyte-derived high affinity CXC-chemokine ligand for the IP-10/Mig receptor (CXCR3)
115. The CXC-chemokine, H174: Expression in the central nervous system
116. Use of a selectable marker regulated by α interferon to obtain mutations in the signaling pathway
117. Induction of β-R1/I-TAC by interferon-β requires catalytically-active TYK2
118. Catalytically-active TYK2 is essential for interferon-β-mediated phosphorylation of STAT3 and interferon α/β receptor chain (IFNAR)-1 but not for the activation of phosphoinositol 3-kinase